SF
San Francisco Sentry Investment Group (Ca)
13F filer · CIK 0001540142Last filed Aug 2, 2021
Inactive · not filing 13F
13F portfolio value$192MU.S. long equity reported on 13F
Positions515Not reported new · Not reported closed
Net flow last quarterNot reportedBuys minus sells
Top 10 positions weight24.2%Concentration
Holdings
13F · last 4 quarters freeScroll for earlier quarters
| Company | Value | % of portfolio | % of company | POSITION CHANGE qoq % | First reported |
|---|---|---|---|---|---|
| Q2 2021Reported Aug 2, 2021515 positions | |||||
| $8.04M | 4.19% | 0.40% | Not reported | Q4 2020 | |
| $7.79M | 4.06% | 0.00% | -14.4% | Q2 2013 | |
| $7.1M | 3.70% | 0.00% | -53.6% | Q2 2013 | |
| $5.09M | 2.65% | 0.00% | -34.7% | Q2 2013 | |
| $3.92M | 2.04% | 0.00% | -28.4% | Q4 2015 | |
| $3.65M | 1.90% | 0.00% | +0.7% | Q2 2013 | |
| $3.25M | 1.69% | 0.00% | -37.0% | Q2 2013 | |
| $2.82M | 1.47% | 0.00% | +0.9% | Q2 2013 | |
| $2.82M | 1.47% | Not reported | -32.1% | Q4 2015 | |
| $2.04M | 1.06% | Not reported | -0.2% | Q2 2013 | |
| $2.01M | 1.05% | 0.00% | +0.2% | Q2 2013 | |
| $1.96M | 1.02% | Not reported | -0.3% | Q2 2013 | |
| $1.92M | 1.00% | 0.00% | -58.8% | Q2 2013 | |
| $1.82M | 0.95% | 0.00% | -11.5% | Q2 2013 | |
| ABADVMAdverum Biotechnologies, Inc. | $1.68M | 0.88% | 0.49% | Not reported | Q4 2017 |
| $1.64M | 0.85% | 0.00% | -37.8% | Q2 2013 | |
| $1.52M | 0.79% | Not reported | +2.5% | Q3 2013 | |
| $1.51M | 0.79% | 0.00% | -0.8% | Q2 2013 | |
| $1.37M | 0.71% | Not reported | -0.2% | Q2 2013 | |
| $1.34M | 0.70% | 0.00% | -1.2% | Q2 2013 | |
| $1.25M | 0.65% | 0.00% | +1.9% | Q2 2013 | |
| $1.24M | 0.65% | 0.00% | +8.4% | Q2 2017 | |
| $1.23M | 0.64% | 0.00% | +1.3% | Q2 2013 | |
| $1.21M | 0.63% | 0.00% | +0.3% | Q2 2017 | |
| $1.16M | 0.60% | 0.00% | -44.2% | Q2 2013 | |
| $1.1M | 0.57% | 0.00% | +0.8% | Q2 2013 | |
| $1.08M | 0.56% | 0.00% | -67.9% | Q2 2013 | |
| $1.04M | 0.54% | 0.00% | +1.0% | Q2 2013 | |
| $1.03M | 0.54% | 0.00% | -50.1% | Q2 2013 | |
| $1.01M | 0.52% | 0.00% | +4.3% | Q2 2017 | |
| $982K | 0.51% | 0.00% | -24.4% | Q2 2013 | |
| $978K | 0.51% | 0.00% | -7.0% | Q2 2013 | |
| $973K | 0.51% | 0.00% | -11.0% | Q2 2013 | |
| $926K | 0.48% | 0.00% | +10.7% | Q2 2013 | |
| $913K | 0.48% | 0.00% | +38.7% | Q2 2013 | |
| $901K | 0.47% | 0.00% | -49.1% | Q3 2017 | |
| $878K | 0.46% | 0.00% | Not reported | Q2 2013 | |
| $859K | 0.45% | 0.00% | +0.8% | Q2 2013 | |
| $853K | 0.44% | 0.02% | Not reported | Q2 2014 | |
| $849K | 0.44% | 0.00% | +3.4% | Q2 2013 | |
| $814K | 0.42% | 0.00% | Not reported | Q2 2017 | |
| $813K | 0.42% | 0.00% | +2.8% | Q2 2013 | |
| $812K | 0.42% | Not reported | +16.7% | Q2 2017 | |
| $799K | 0.42% | 0.00% | -0.1% | Q2 2013 | |
| $768K | 0.40% | 0.00% | +13.2% | Q2 2013 | |
| $753K | 0.39% | 0.00% | +2.9% | Q2 2013 | |
| $732K | 0.38% | 0.00% | -20.5% | Q2 2013 | |
| $732K | 0.38% | 0.00% | -6.1% | Q2 2013 | |
| $727K | 0.38% | 0.00% | -43.5% | Q2 2013 | |
| $718K | 0.37% | Not reported | +3.1% | Q2 2018 | |
| Q1 2021Reported Apr 23, 2021540 positions | |||||
| $13.6M | 5.80% | 0.00% | -1.1% | Q2 2013 | |
| $8.18M | 3.48% | 0.00% | -10.5% | Q2 2013 | |
| $6.78M | 2.89% | 0.00% | +1.6% | Q2 2013 | |
| $4.93M | 2.10% | 0.00% | +1.5% | Q2 2013 | |
| $4.75M | 2.02% | 0.40% | Not reported | Q4 2020 | |
| ABADVMAdverum Biotechnologies, Inc. | $4.73M | 2.02% | 0.49% | Not reported | Q4 2017 |
| $4.62M | 1.97% | 0.00% | +1.7% | Q4 2015 | |
| $4.22M | 1.80% | 0.00% | +0.8% | Q2 2013 | |
| $3.58M | 1.52% | 0.00% | +0.5% | Q2 2013 | |
| $3.43M | 1.46% | Not reported | +1.8% | Q4 2015 | |
| $2.77M | 1.18% | 0.00% | +0.4% | Q2 2013 | |
| $2.73M | 1.16% | 0.00% | Not reported | Q2 2013 | |
| $2.5M | 1.06% | 0.00% | +0.4% | Q2 2013 | |
| $2.43M | 1.03% | 0.00% | -0.5% | Q2 2013 | |
| $2.21M | 0.94% | 0.00% | -0.1% | Q2 2013 | |
| $2.14M | 0.91% | 0.00% | +2.5% | Q2 2013 | |
| $2.05M | 0.87% | 0.00% | +2.5% | Q2 2013 | |
| $2.01M | 0.86% | 0.00% | +2.7% | Q2 2013 | |
| $1.96M | 0.83% | 0.00% | +0.8% | Q2 2013 | |
| $1.88M | 0.80% | Not reported | +2.5% | Q2 2013 | |
| $1.82M | 0.77% | Not reported | -1.7% | Q2 2013 | |
| $1.72M | 0.73% | 0.01% | -23.5% | Q3 2017 | |
| $1.68M | 0.72% | 0.00% | +3.0% | Q3 2013 | |
| $1.54M | 0.66% | 0.03% | +0.4% | Q4 2020 | |
| $1.42M | 0.60% | Not reported | +0.1% | Q3 2013 | |
| $1.31M | 0.56% | 0.00% | +6.6% | Q2 2013 | |
| $1.24M | 0.53% | 0.00% | +4.0% | Q2 2013 | |
| $1.23M | 0.52% | 0.00% | +1.7% | Q2 2017 | |
| $1.21M | 0.52% | 0.00% | +135.6% | Q2 2013 | |
| $1.21M | 0.52% | 0.00% | +7.1% | Q2 2013 | |
| $1.2M | 0.51% | 0.00% | -4.3% | Q2 2013 | |
| $1.16M | 0.49% | Not reported | -1.7% | Q2 2013 | |
| $1.14M | 0.48% | 0.00% | -3.2% | Q2 2013 | |
| $1.14M | 0.48% | 0.00% | -2.5% | Q2 2013 | |
| $1.12M | 0.48% | 0.00% | +9.7% | Q2 2017 | |
| $1.1M | 0.47% | 0.00% | -0.1% | Q2 2013 | |
| $1.09M | 0.46% | 0.00% | +2.9% | Q2 2013 | |
| $1.03M | 0.44% | 0.00% | +14.7% | Q2 2013 | |
| $992K | 0.42% | Not reported | +68.7% | Q2 2013 | |
| $970K | 0.41% | 0.02% | -25.1% | Q3 2020 | |
| $957K | 0.41% | 0.00% | +227.8% | Q2 2013 | |
| $929K | 0.40% | 0.00% | -3.8% | Q2 2013 | |
| $929K | 0.40% | Not reported | New | Q1 2021 | |
| $894K | 0.38% | 0.01% | +2.2% | Q1 2019 | |
| $886K | 0.38% | 0.00% | -2.8% | Q2 2013 | |
| $870K | 0.37% | 0.00% | +9.8% | Q2 2013 | |
| $858K | 0.37% | 0.00% | Not reported | Q2 2017 | |
| $835K | 0.36% | 0.00% | +0.6% | Q2 2013 | |
| $829K | 0.35% | 0.00% | +3.3% | Q2 2017 | |
| $824K | 0.35% | 0.00% | -2.2% | Q2 2013 | |
| Q4 2020Reported Feb 1, 2021519 positions | |||||
| $15M | 7.03% | 0.00% | +1.2% | Q2 2013 | |
| $9.62M | 4.52% | 0.00% | +1.8% | Q2 2013 | |
| $6.3M | 2.96% | 0.00% | -1.0% | Q2 2013 | |
| ABADVMAdverum Biotechnologies, Inc. | $5.2M | 2.45% | 0.49% | Not reported | Q4 2017 |
| $4.32M | 2.03% | 0.00% | +0.9% | Q2 2013 | |
| $4.23M | 1.99% | 0.00% | +0.3% | Q2 2013 | |
| $3.86M | 1.81% | 0.00% | +0.3% | Q4 2015 | |
| $3.69M | 1.74% | 0.00% | +0.3% | Q2 2013 | |
| $2.97M | 1.39% | 0.40% | New | Q4 2020 | |
| $2.87M | 1.35% | 0.00% | -2.4% | Q2 2013 | |
| $2.85M | 1.34% | Not reported | -3.7% | Q4 2015 | |
| $2.57M | 1.21% | 0.00% | -1.4% | Q2 2013 | |
| $2.54M | 1.19% | 0.00% | +0.8% | Q2 2013 | |
| $2.41M | 1.13% | 0.00% | +0.2% | Q2 2013 | |
| $2.13M | 1.00% | 0.00% | -0.4% | Q2 2013 | |
| $1.97M | 0.93% | 0.01% | -4.9% | Q3 2017 | |
| $1.96M | 0.92% | 0.00% | +0.8% | Q2 2013 | |
| $1.95M | 0.91% | 0.00% | +0.2% | Q2 2013 | |
| $1.75M | 0.82% | Not reported | -6.2% | Q2 2013 | |
| $1.73M | 0.81% | 0.00% | +21.2% | Q2 2013 | |
| $1.66M | 0.78% | Not reported | -0.4% | Q2 2013 | |
| $1.64M | 0.77% | 0.00% | -39.2% | Q2 2013 | |
| $1.58M | 0.74% | 0.00% | Not reported | Q3 2013 | |
| $1.37M | 0.64% | 0.03% | New | Q4 2020 | |
| $1.32M | 0.62% | 0.00% | +0.4% | Q2 2017 | |
| $1.32M | 0.62% | 0.03% | +20428.6% | Q3 2020 | |
| $1.31M | 0.62% | Not reported | +8.0% | Q3 2013 | |
| $1.31M | 0.61% | 0.00% | +0.8% | Q2 2013 | |
| $1.25M | 0.59% | 0.00% | +2.0% | Q2 2013 | |
| $1.21M | 0.57% | 0.00% | +1.3% | Q2 2013 | |
| $1.2M | 0.56% | 0.00% | +81.5% | Q2 2013 | |
| $1.13M | 0.53% | 0.00% | +3.4% | Q2 2013 | |
| $1.11M | 0.52% | 0.00% | +7.3% | Q2 2013 | |
| $1.1M | 0.52% | 0.00% | +10.8% | Q2 2013 | |
| $1.1M | 0.51% | Not reported | -0.2% | Q2 2013 | |
| $1.05M | 0.50% | 0.00% | +8.6% | Q2 2013 | |
| $1M | 0.47% | 0.00% | +5.3% | Q2 2013 | |
| $967K | 0.45% | 0.00% | +1.5% | Q2 2013 | |
| $962K | 0.45% | 0.00% | -0.9% | Q2 2013 | |
| $961K | 0.45% | 0.00% | +4.1% | Q2 2017 | |
| $953K | 0.45% | 0.00% | +13.9% | Q2 2013 | |
| $915K | 0.43% | 0.00% | -1.4% | Q2 2013 | |
| $861K | 0.40% | 0.00% | +2.6% | Q2 2013 | |
| $839K | 0.39% | 0.00% | -1.0% | Q2 2017 | |
| $838K | 0.39% | 0.00% | -1.9% | Q2 2013 | |
| $794K | 0.37% | 0.00% | +7.3% | Q2 2013 | |
| $777K | 0.37% | 0.00% | -2.0% | Q2 2013 | |
| $772K | 0.36% | 0.00% | 0.0% | Q2 2013 | |
| $748K | 0.35% | 0.00% | +2.7% | Q2 2017 | |
| $736K | 0.35% | 0.02% | -6.4% | Q2 2020 | |
| Q3 2020Reported Oct 14, 2020512 positions | |||||
| $12.9M | 6.62% | 0.00% | -15.4% | Q2 2013 | |
| $9.14M | 4.69% | 0.00% | +2.5% | Q2 2013 | |
| $6.02M | 3.09% | 0.00% | -0.4% | Q2 2013 | |
| ABADVMAdverum Biotechnologies, Inc. | $4.94M | 2.54% | 0.60% | Not reported | Q4 2017 |
| $4.41M | 2.26% | 0.00% | -0.7% | Q2 2013 | |
| $3.92M | 2.01% | 0.00% | -19.6% | Q2 2013 | |
| $3.41M | 1.75% | 0.00% | -0.7% | Q2 2013 | |
| $3.22M | 1.65% | 0.00% | -14.0% | Q4 2015 | |
| $2.88M | 1.48% | 0.00% | -15.1% | Q2 2013 | |
| $2.83M | 1.45% | 0.01% | +0.4% | Q1 2019 | |
| $2.77M | 1.42% | 0.00% | +1.6% | Q2 2013 | |
| $2.68M | 1.37% | 0.00% | +0.3% | Q2 2013 | |
| $2.49M | 1.28% | Not reported | -16.8% | Q4 2015 | |
| $2.39M | 1.23% | 0.00% | +0.9% | Q2 2013 | |
| $2.12M | 1.09% | 0.00% | -18.4% | Q2 2013 | |
| $2.04M | 1.05% | 0.00% | -12.6% | Q2 2013 | |
| $2.03M | 1.04% | 0.00% | -6.6% | Q2 2013 | |
| $1.9M | 0.97% | 0.01% | Not reported | Q3 2017 | |
| $1.84M | 0.94% | 0.00% | +1.0% | Q2 2013 | |
| $1.67M | 0.86% | Not reported | +7.3% | Q2 2013 | |
| $1.53M | 0.79% | Not reported | +2.9% | Q2 2013 | |
| $1.5M | 0.77% | 0.00% | -1.8% | Q2 2013 | |
| $1.2M | 0.62% | 0.00% | +4.8% | Q3 2013 | |
| $1.17M | 0.60% | 0.00% | -0.5% | Q2 2013 | |
| $1.15M | 0.59% | 0.00% | -1.7% | Q2 2013 | |
| $1.15M | 0.59% | 0.00% | -1.1% | Q2 2013 | |
| $1.12M | 0.58% | 0.00% | +2.2% | Q2 2013 | |
| $1.1M | 0.57% | Not reported | +4.5% | Q3 2013 | |
| $1.09M | 0.56% | 0.00% | +0.1% | Q2 2013 | |
| $1.07M | 0.55% | 0.00% | -0.3% | Q2 2013 | |
| $1.05M | 0.54% | 0.00% | +4.0% | Q2 2017 | |
| $1.05M | 0.54% | Not reported | -0.5% | Q2 2013 | |
| $1M | 0.51% | 0.00% | -2.8% | Q2 2013 | |
| $964K | 0.49% | 0.00% | -3.8% | Q2 2013 | |
| $925K | 0.47% | 0.00% | -18.6% | Q2 2013 | |
| $921K | 0.47% | 0.00% | Not reported | Q2 2013 | |
| $919K | 0.47% | 0.00% | -5.0% | Q2 2013 | |
| $899K | 0.46% | 0.00% | -2.9% | Q2 2013 | |
| $878K | 0.45% | Not reported | +3.8% | Q2 2020 | |
| $855K | 0.44% | 0.00% | -0.2% | Q2 2017 | |
| $806K | 0.41% | 0.00% | +0.6% | Q2 2020 | |
| $798K | 0.41% | 0.00% | +2.8% | Q2 2017 | |
| $788K | 0.40% | 0.02% | +0.5% | Q2 2020 | |
| $782K | 0.40% | 0.00% | -6.7% | Q2 2013 | |
| $768K | 0.39% | 0.00% | -0.2% | Q2 2017 | |
| $755K | 0.39% | 0.00% | -2.2% | Q2 2013 | |
| $718K | 0.37% | 0.00% | -0.1% | Q2 2013 | |
| $718K | 0.37% | 0.00% | Not reported | Q2 2013 | |
| $713K | 0.37% | 0.00% | -0.3% | Q2 2013 | |
| $701K | 0.36% | 0.00% | -0.2% | Q2 2013 | |
Premium opens every quarter this fund has filed